Chemotherapy in Malignant Gynaecologic Tumours

Arnold H. Bourseaux F. Brock : Synthese und Abbau zytostatisch wirksamer zyklischer N-Phosphamid-ester des Bis-(beta-chloraethyl)-amins. Angew. Chem. 70 (1958), 539.

Bateman J. C. : Chemotherapy of solid tumours with triethylene thiophosphoramide. New Engl. J. Med. 252 (1955), 879.

Bateman J. C. Palliation of cancer in human patients by maintenance therapy with NN′N″-triethylene thiophosphoramide and N-(3-oxapentamethylene)-N′N″-diethylene phosphoramide. Ann. N. Y. Acad. Sci. 68 (1958), 1057.

Bateman J. C. Carlton H. N. : Chemotherapeutic control of cancer. Am. Med. Ass. Miami, June 13, 1960.

Blixencrone-Møller N. : Cancer og Kemotherapeutica (Danish). Nord. Med. 64 (1960), 49.

Bourquin J. P. Schwarb C. Gamboni G. et coll.: Syntesen auf dem Phenothiazin-Gebiet. Helv. chim. Acta 41 (1958), 1072.

Brockmann H. Brulhafer N. : Actinomycin C. Naturwiss. 36 (1949), 376.

Broquist H. P. : Evidence for the excretion of formimino-glutamic acid following folic acid antagonist therapy in acute leukemia. J. Amer. Chem. Soc. 78 (1956), 6205.

Brunschwig A. : Experiences with E-39 in the treatment of advanced malignant neoplasms. Cancer 11 (1958,), 765.

Burchenal J. H. Oettgen H. F. Reppert J. A. Coley V. : The effect of actinomycins and their derivatives on a spectrum of transplanted mouse leukemia. Ann. N. Y. Acad. Sci. 89 (1960), 399.

Carlsson A. : Om själslivets farmakologi och biokemi (Swedish). Acta Universitat. Gothenburg. 66 (1960), 1.

Cohen S. : TP-21, a new Phenothiazine. Amer. J. Psychiatr. 115 (1948), 358.

Domagk G. : Chemotherapy of cancer by ethylenimino quinones: Its foundation and problems. Ann. N. Y. Acad. Sci. 68 (1958), 1197.

Farber S. D'Angio G. Evans A. Mitus A. : Clinical studies of actinomycin D with special reference to Wilm's tumor in children. Ann. N. Y. Acad. Sci. 89 (1960), 421.

Farber S. D'Angio G. Evans A. Mitus A. Cutler E. C. Hawkins J. W. et coll.: The action of pteroylglutamic conjugates on man. Science 106 (1947), 619.

Farber S. D'Angio G. Evans A. Mitus A. Diamond L. K. Mercer R. D. et coll.: Temporary remissions in acute leukemia in children produced by folic acid antagonists, 4-aminopteroyl-glutamic acid (Aminopterin). New Engl. J. Med. 238 (1948), 787.

Fleeson W. Glueck B. Heistad G. et coll.: The ataraxic effect of two phenothiazine drugs on an out-patient population. Univ. Minn. med. Bull. 29 (1958), 274.

Goldsmith E. G. : Reserpine, a potentiator of the inhibitory action of Aminopterin on the development of the fruit fly. Proc. Amer. Ass. Cancer Res. 2 (1958), 301.

Griswold M. H. Wilder C. S. Cutler S. J. Pollack E. S. : Cancer in Connecticut 1935–1951. State Dep. of Health, Hartford, Conn., 1955.

Gynning J. Claesson L. : The effect of 9-delta-Br-11-beta ketoprogesterone on lung metastatic carcinoma in a patient with cancer of the uterine corpus. Cancer (In press).

Hansen H. A. : Folic acid, B-12-vitamin och serum-Fe under den normala graviditeten (Swedish). Nord. Med. 61 (1959), 842.

Heidelberger C. Chaudhuri N. K. Danneberg P. et coll.: Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179 (1957), 663.

Hertz R. Bergenstal D. M. Lipsett M. B. et coll.: Chemotherapy of choriocarcinoma and related trophoblastic tumors in women. J. Amer. med. Ass. 168 (1958), 845.

Homburger F. : The biologic basis of cancer management. Hoeber-Harper, New York 1957.

Hreschchyshyn M. M. Graham J. B. : Chemotherapy in patients with gynecologic neoplasms with three different alkylating agents: TSPA, A-139 and B 518. Proc. Amer. Ass. Cancer Res. 3 (1958), 28.

Karnofsky D. A. : Chemotherapy of malignant diseases. Antibiot. et Chemother. (Basel) 8 (1960), 194.

Kottmeier H-L. : Personal communication (1960).

Koyama Y. Tokuyama H. : Clinical experience with nitromin. Ann. N. Y. Acad. Sci. 68 (1958), 1105.

Larionov L. F. : The present status and future prospects of cancer chemotherapy by alkylating agents. Acta Un. int. Cancr. 15 (1959), 42.

Norin T. Rosengren B. : Personal communication (1961).

Peters K. Gärtner H. Krais W. : Über die alleinige oder kombinierte Wirkung von Radium und Megaphen auf den Mäuseascitestumor. Strahlentherapie 97 (1955), 579.

Ravina A. Pestel M. : The clinical applications and methods of administration of actinomycin in the treatment of different tumours. Ann. N. Y. Acad. Sci. 89 (1960), 463.

Remy M. : Essai d'un nouveau dérivé de la phénothiazine, le Melléril, en clinique psychiatrique. Schweiz. Med. Wschr. 88 (1958), 1221.

Rounds D. E. Nakanishi Y. H. Pomerat C. M. : Possible mechanisms to explain the action of actinomycin on nonmalignant and malignant cells. Antibiot. and Chemother. 10 (1960), 10.

Schulte G. : Erfahrungen mit neuen cytostatischen Mitteln bei Haemoblastosen und Carcinomen und die Abgrenzung ihrer Wirkungen gegen Roentgentherapie. Z. Krebsforsch. 58 (1952), 500.

Seegar D. R. Smith J. M. Jr. Hultquist M. E. : Antagonists for pteroylglutamic acid. J. Amer. chem. Soc. 69 (1947), 2567.

Slotnick J. J. : Mechanism of action of actinomycin D in microbiological systems. Ann. N. Y. Acad. Sci. 89 (1960), 342.

Tabor H. Wyngarden L. : A method for the determination of formiminoglutamic acid in urine. J. Clin. Invest. 37 (1958), 824.

Taeschler M. Cerletti A. : Zur Pharmakologie von Thioridazin, Melleril. Schweiz. Med. Wschr. 88 (1958), 1216.

Tan Ch. T. C. Golbey R. B. Yap C. L. et coll.: Clinical experiences with actinomycins D, KS2, and F1 (KS4). Ann. N. Y. Acad. Sci. 89 (1960), 426.

Truhaut R. Boiron M. Thomas M. Pierart A. : Etude sur le traitement des cancers par le N-N-bis (betachloréthyl) diamide de l'ester NO-propylène-phosphorique (Cyclophosphamide). Chemotherapia 3 (1960), 137.

Waksman S. A. Woodruff H. B. : Bacteriostatic and bactericidal substances produced by a soil actinomyces. Proc. Soc. exp. Biol. 45 (1940), 609.

Watne A. L. Badille J. Koike A. et coll.: Clinical studies of actinomycin D. Ann. N. Y. Acad. Sci. 89 (1960), 445.

Wilmanns H. : Chemotherapie maligner Tumoren. ASTA, Forschung und Therapie, Mai 1958.